Paul Janssen

Description

Paul Janssen was the founder of Janssen Pharmaceuticals.

Investor Profile

Paul Janssen has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

Series D (100%)

Country Focus

Switzerland (100%)

Industry Focus

Biotechnology
Health Diagnostics
Medical Device

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Paul Janssen frequently co-invest with?

New Rhein

North America, Pennsylvania, United States, Philadelphia

Co-Investments: 1

Korys

Europe, Vlaams-Brabant, Belgium, Halle

Co-Investments: 1

Benaruca

Europe, Luxembourg, Luxembourg, Luxembourg

Co-Investments: 1

Johnson & Johnson Development Corporation

North America, New Jersey, United States, New Brunswick

Co-Investments: 1

Debiopharm Group

Europe, Vaud, Switzerland, Lausanne

Co-Investments: 1

PMV Tina Fund

Co-Investments: 1

RMM

Europe, Oost-Vlaanderen, Belgium, Gent

Co-Investments: 1

Valiance Asset Management

Europe, NA - Guernsey, Guernsey, St. Peter Port

Co-Investments: 1

Philips Venture Capital Fund

Europe, Noord-Brabant, The Netherlands, Eindhoven

Co-Investments: 1

Which angels does Paul Janssen often collaborate with?

Luc Verelst

Shared Deals: 1

What are some of recent deals done by Paul Janssen?

Biocartis

Lausanne, Vaud, Switzerland

Biocartis develops a diagnostics technology platform for the multiplexed detection of bio-analytes.

BiotechnologyHealth DiagnosticsMedical Device

Series DDec 12, 2012

Amount Raised: $45,032,933

Paul Janssen

Description

Investor Profile

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does Paul Janssen frequently co-invest with?

Which angels does Paul Janssen often collaborate with?

What are some of recent deals done by Paul Janssen?

Ready to Raise Capital?

Pages

Free tools